1Englyst, HN, Kingman, SM & Cummings, JH (1992) Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr 46, S33–S50.
2EURESTA (1992) Resistant starch. Proceedings of the 2nd Plenary Meeting of EURESTA: European FLAIR-Concerted Action No. 11 on physiological implications of the consumption of resistant starch in man. Eur J Clin Nutr 46, S1–S148.
3Topping, DL & Clifton, PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031–1064.
4Brouns, F, Kettlitz, B & Arrigoni, E (2002) Resistant starch and ‘the butyrate revolution’. Food Sci Technol Int 13, 251–261.
5Hijova, E & Chmelarova, A (2007) Short chain fatty acids and colonic health. Bratisl Lek Listy 108, 354–358.
6Annison, G, Illman, RJ & Topping, DL (2003) Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J Nutr 133, 3523–3528.
7Henningsson, AM, Bjorck, IM & Nyman, EM (2002) Combinations of indigestible carbohydrates affect short-chain fatty acid formation in the hindgut of rats. J Nutr 132, 3098–3104.
8Cummings, JH & Macfarlane, GT (1991) The control and consequences of bacterial fermentation in the human large intestine. J Appl Bacteriol 70, 443–459.
9Behall, KM, Hallfrisch, JG, Scholfield, DJ, et al. (2006) Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care 29, 976–981.
10Park, OJ, Kang, NE, Chang, MJ, et al. (2004) Resistant starch supplementation influences blood lipid concentrations and glucose control in overweight subjects. J Nutr Sci Vitaminol 50, 93–99.
11Jeppesen, J, Schaaf, P, Jones, C, et al. (1997) Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr 65, 1027–1033.
12Coutinho, M, Gerstein, HC, Wang, Y, et al. (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22, 233–240.
13Zhang, WW, Bi, JC & Yan, XY (2007) In vitro measurement of resistant starch of cooked milled rice and physico-chemical characteristics affecting its formation. Food Chem 105, 462–468.
14Le Leu, RK, Brown, IL, Hu, Y, et al. (2007) Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis 28, 240–245.
15Robertson, MD, Bickerton, AS, Dennis, AL, et al. (2005) Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82, 559–567.
16Hedemann, MS & Knudsen, KE (2007) Resistant starch for weaning pigs – effect on concentration of short chain fatty acids in digesta and intestinal morphology. Livestock Sci 108, 175–177.
17Higgins, JA (2004) Resistant starch: metabolic effects and potential health benefits. J AOAC Int 87, 761–768.
18Behall, KM & Hallfrisch, J (2002) Plasma glucose and insulin reduction after breads varying in amylose content. Eur J Clin Nutr 56, 913–920.
19Levitt, MD (1969) Production and excretion of H2 gas in man. N Engl J Med 81, 122–127.
20Wilkens, LR, Le Marchand, L, Harwood, P, et al. (1994) Use of breath H2 and methane as markers of colonic fermentation in epidemiological studies: variability in excretion. Cancer Epidemiol Biomarkers Prev 3, 149–153.
21Bond, JH & Levitt, MD (1972) Use of pulmonary H2 (H2) measurements to quantitate carbohydrate absorption: study of partially gastrectomized patients. J Clin Invest 51, 1219–1225.
22Tormo, R, Bertaccini, A, Conde, M, et al. (2001) Methane and H2 exhalation in normal children and in lactose malabsorption. Early Human Dev 65, S165–S172.
23Wolever, TM, Jenkins, DJ, Jenkins, AL, et al. (1991) The glycemic index: methodology and clinical implications. Am J Clin Nutr 54, 846–854.
24Brand-Miller, JC, Fatema, K, Middlemiss, C, et al. (2007) Effect of alcoholic beverages on postprandial glycemia and insulinemia in lean, young, healthy adults. Am J Clin Nutr 85, 1545–1551.
25Granfeldt, Y, Drews, A & Bjorck, I (1995) Arepas made from high amylose corn flour produce favorably low glucose and insulin response in healthy humans. J Nutr 125, 459–465.
26Behall, KM, Hallfrisch, JG, Scholfield, DJ, et al. (2006) Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care 29, 976–981.
27Park, OJ, Kand, NE, Chang, MJ, et al. (2004) Resistant starch supplementation influences blood lipid concentrations and glucose control in overweight subjects. J Nutr Sci Vitaminol 50, 93–99.
28Yamada, Y, Hosoya, S, Nishimura, S, et al. (2005) Effect of bread containing resistant starch on postprandial blood glucose levels in humans. Biosci Biotechnol Biochem 69, 559–566.
29Behall, KM & Hallfrisch, J (2002) Plasma glucose and insulin reduction after consumption of breads varying in amylose content. Eur J Clin Nutr 56, 913–920.
30Le Leu, RK, Brown, IL, Hu, Y, et al. (2003) Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and luminal contents in rats. Carcinogenesis 24, 1347–1352.
31Li, M, Piao, JH, Liu, QQ, et al. (2008) Effects of the genetically modified rice enriched with resistant starch on large bowel health in rats. Acta Nutr Sin 30, 588–591.
32Musch, MW, Bookstein, C, Xie, Y, et al. (2001) SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol 280, G687–G693.
33Vernia, P, Annese, V, Bresci, G, et al. (2003) Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 33, 244–248.
34Luhrs, H, Gerke, T, Schauber, J, et al. (2001) Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short chain fatty acid butyrate. Int J Colorect Dis 16, 195–201.
35Bauer, MM, Florian, S, Muller, SK, et al. (2006) Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. Carcinogenesis 27, 1849–1859.
36Dashwood, RH, Myzak, MC & Ho, E (2006) Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27, 344–349.
37Mortensen, PB & Clausen, MR (1996) Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 216, 132–148.
38Symonds, EL, Kritas, S, Omari, TI, et al. (2004) A combined 13CO2/H2 breath test can be used to assess starch digestion and fermentation in humans. J Nutr 134, 1193–1196.
39Christian, MT, Amarri, S, Franchini, F, et al. (2002) Modeling 13C breath curves to determine site and extent of starch digestion and fermentation in infants. J Pediatr Gastroenterol Nutr 34, 158–164.
40Asp, ML, Hertzler, SR, Chow, J, et al. (2006) Gamma-cyclodextrin lowers postprandial glycemia and insulinemia without carbohydrate malabsorption in healthy adults. J Am Coll Nutr 25, 49–55.
41Jenkins, DJ, Vuksan, V, Kendall, CW, et al. (1998) Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr 17, 609–616.